Malignancy-associated pruritus.
Rowe B, Yosipovitch G.
Eur J Pain. 2016 Jan;20(1):19-23. doi: 10.1002/ejp.760. Epub 2015 Sep 28.
COLON CANCER.
TAYLOR SG 3rd, SOUTHWICK HW, HENDRICKSON FR.
Med Clin North Am. 1964 Jan;48:215-26. doi: 10.1016/s0025-7125(16)33497-6.
KAPOSI'S SARCOMA.
DAVIES JN.
Trans St Johns Hosp Dermatol Soc. 1963;49:93-8.
Immune characterization of thyroid neoplasm's and its variants using immunohistochemical markers: CK-19, Galectin-3 and Hector Battifora mesothelial-1.
Nehal S, Mittal R, Misra P, Rath J, Senapati U.
Ann Diagn Pathol. 2022 Jun;58:151931. doi: 10.1016/j.anndiagpath.2022.151931. Epub 2022 Mar 2.
Invasion and metastasis: a historical perspective.
Patriarca C, Pini GM, Conti G.
Pathologica. 2020 Dec;112(4):229-233. doi: 10.32074/1591-951X-111.
COMBINED TUMOUR.
PUGH RC, THACKRAY AC.
Br J Urol. 1964 Jun;36:SUPPL:45-51.
OSTEOGENIC SARCOMA.
ROSS FG.
Br J Radiol. 1964 Apr;37:259-76. doi: 10.1259/0007-1285-37-436-259.
ENDOMETRIAL CARCINOMA.
Meares SD.
Aust N Z J Obstet Gynaecol. 1963 Dec;3(4):182-90. doi: 10.1111/j.1479-828x.1963.tb00243.x.
Immunological challenges and opportunities in glioblastoma multiforme: A comprehensive view from immune system lens.
Bhardwaj JS, Paliwal S, Singhvi G, Taliyan R.
Life Sci. 2024 Nov 15;357:123089. doi: 10.1016/j.lfs.2024.123089. Epub 2024 Oct 1.
[Cancer as secondary immunodeficiency. Review].
Vargas-Camaño ME, Guido-Bayardo RL, Martínez-Aguilar NE, Castrejón-Vázquez MI.
Rev Alerg Mex. 2016 Apr-Jun;63(2):169-79. doi: 10.29262/ram.v63i2.176.
